Searched for
BIOCON STOCK PERFORMANCE
West Bengal's electronics factory push; Fed jitters hit TCSWest Bengal is exploring ways to expand electronics manufacturing under EMC 2.0. This and more in today's ETtech Top 5.- Bernstein initiates coverage on 6 pharma stocks, cites 3 major tailwinds for healthcare sectorBernstein has initiated coverage on six Indian pharma stocks, with Zydus Lifesciences as its top choice. The brokerage sees strong future g...
- Laurus Labs adds Rs 40,150 crore to investors' wealth in a year with 120% rally. Buy, hold or book profits?Laurus Labs has significantly boosted investor wealth, adding over Rs 40,000 crore in a year with a 120% stock rally. Driven by business im...
- Stocks in news: Paytm, Bajaj Auto, L&T, Bharti Airtel, Hero MotoCorpMarkets closed lower amid global headwinds and geopolitical worries. Several companies like Paytm, Bajaj Auto, and L&T are in focus due to ...
- Syngene shares zoom 17% even as firm’s Q4 net profit drops 19% YoY. What's driving the surge?Syngene shares surged despite a 19% YoY decline in Q4FY26 net profit to Rs 148 crore, as earnings rebounded sharply from Rs 15 crore in the...
- Iran war halts but missiles would echo in Q4 results: 40 stocks may report over 20% profit dipIndia's corporate earnings for the quarter ended March 2026 are feeling the economic heat from the recent Israel-US-Iran conflict. While so...
- Bullish on these 7 sectors; Biocon and Nykaa are two top picks: CA Rudramurthy BVExpert CA Rudramurthy BV suggests a bullish stance. He recommends buying on dips, especially in pharma stocks like Glenmark, Laurus Labs, a...
- Biocon shares in focus after launching QIP at floor price of Rs 340.20Biocon shares: The decision comes after receiving approvals from the Board of Directors in April and from shareholders through a postal bal...
- Biocon shares fall 3% after board approves fundraise of up to Rs 4,500 croreBiocon shares: The board approved a hike in the company’s authorised share capital from Rs 625 crore to Rs 700 crore, along with a correspo...
- Biocon shares surge over 4% after Malaysia unit gets clearance from the USFDABiocon shares increased by 4.5% after the US FDA classified its Malaysian insulin facilities as Voluntary Action Indicated. This followed a...
- Biocon shares zoom 4% as Jefferies upgrades to "hold" amid positive news inflow, sets Rs 400 targetBiocon share price: This upgrade reflects a more positive outlook on the company following recent favorable news flow, particularly concern...
- Biocon shares surge 5% after USFDA classifies Bengaluru site as VAIBiocon Share Price: Biocon shares surged 5.4% after FDA classified its Bengaluru facility as Voluntary Action Indicated (VAI). The stock is...
- Biocon denies plans to sell $1.5 billion generic API businessBiocon API business: Biocon has refuted claims of considering the sale of its generic active pharmaceutical ingredient (API) business, valu...
- Buy Biocon, target price Rs 425: ICICI DirectBiocon Ltd., incorporated in the year 1978, is a Large-Cap company (with a market cap of Rs 43209.59 Crore) operating in Pharmaceuticals se...
- Biocon posts marginal 2 per cent growth in net profit for Q4FY18Biocon posted a net profit of Rs 130 crore for the quarter ended March 31, 2018. The company had recorded a net profit of Rs 127 crore for ...
- Biocon has little room to slip up after strong 2016At the end of 2015, 70% of analysts tracking the Biocon stock had a buy recommendation on it. Data from Bloomberg show that this number has...
- Biocon, Piramal & GSK buck the pharma trend, outperform amid absence of FDA issuesWhile most pharma companies have turned risky on account of regulatory clamps, investors have switched to companies with healthy pipeline a...
- Analysis: Can Syngene IPO Change Biocon's Fortunes?Contributing one-fourth of the consolidated revenues, Syngene has been Biocon's best-performing segment in the last couple of years.
- Return ratios for Biocon to remain tepid; prefer Sun Pharma among pharma names: Mayuresh JoshiInvestors must adopt stock-specific approach as valuations have turned expensive on pharma counters, says Joshi in an interview to ET Now.
- Bicon stock can be a really good performer: Pankaj Pandey, ICICI DirectOver the last few days, the developments have been quite positive in Biocon.
Load More
